Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
Quidel Receives Emergency Use Authorization for QuickVue® At-Home COVID-19 Test
11:51am, Monday, 01'st Mar 2021
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,
3 Stocks Trading Below the Peter Lynch Fair Value
11:52am, Wednesday, 24'th Feb 2021
Investors in search of opportunities amid growing companies could be interested in the following three stocks, as their share prices are trading lower than their Peter Lynch Fair Values.
Quidel to Present at Upcoming Conferences
04:10pm, Monday, 22'nd Feb 2021
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced toda
Which Stocks Could Win if the U.S. Requires COVID Tests for Domestic Flights?
11:05am, Saturday, 20'th Feb 2021
It's possible that some stocks could fly higher with the policy change being considered by the Biden administration.
Why Quidel Corporation Stock Is Plunging Today
02:45pm, Friday, 19'th Feb 2021
The company released its fourth-quarter and full-year 2020 earnings report.
Why Investors Didn't Leap for Joy After Quidel's Strong Q4 Performance
06:05am, Friday, 19'th Feb 2021
The diagnostics company delivered impressive top- and bottom-line growth. But it wasn't enough to fire up investors.
Quidel's (QDEL) CEO Doug Bryant on Q4 2020 Results - Earnings Call Transcript
10:14pm, Thursday, 18'th Feb 2021
Quidel's (QDEL) CEO Doug Bryant on Q4 2020 Results - Earnings Call Transcript
Quidel: Q4 Earnings Insights
04:22pm, Thursday, 18'th Feb 2021
Shares of Quidel (NASDAQ:QDEL) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 1007.00% over the past year to $11.07, which bea
Quidel Reports Fourth Quarter and Full Year 2020 Financial Results
04:10pm, Thursday, 18'th Feb 2021
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financ
Why Quidel Corp (QDEL) Might Surprise This Earnings Season
09:52am, Wednesday, 17'th Feb 2021
Quidel Corp (QDEL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Quidel (QDEL) Gains As Market Dips: What You Should Know
06:56pm, Tuesday, 09'th Feb 2021
Quidel (QDEL) closed the most recent trading day at $236.38, moving +1.5% from the previous trading session.
Mario Gabelli's Top Trades of the 4th Quarter
05:29pm, Monday, 08'th Feb 2021
Mario Gabelli (Trades, Portfolio), founder of GAMCO Investors, has revealed his portfolio for the fourth quarter. Major trades include reductions in his Rollins Inc. (NYSE:ROL), Navistar International
Quidel (QDEL) to Report Q4 Earnings: What's in the Offing?
01:36pm, Thursday, 04'th Feb 2021
Quidel (QDEL) is likely to have witnessed a recovery in rapid immunoassay revenues during Q4.
Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know
06:56pm, Wednesday, 03'rd Feb 2021
Quidel (QDEL) closed at $236.85 in the latest trading session, marking a +1.29% move from the prior day.
Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19
04:10pm, Wednesday, 03'rd Feb 2021
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,
